Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 255


Neu-induced retroviral rat mammary carcinogenesis: a novel chemoprevention model for both hormonally responsive and nonresponsive mammary carcinomas.

Woditschka S, Haag JD, Waller JL, Monson DM, Hitt AA, Brose HL, Hu R, Zheng Y, Watson PA, Kim K, Lindstrom MJ, Mau B, Steele VE, Lubet RA, Gould MN.

Cancer Res. 2006 Jul 1;66(13):6884-91.


Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model.

Woditschka S, Haag JD, Mau B, Lubet RA, Gould MN.

Breast Cancer Res. 2008;10(1):R18. doi: 10.1186/bcr1864. Epub 2008 Feb 15.


A short-term rat mammary carcinogenesis model for the prevention of hormonally responsive and nonresponsive in situ carcinomas.

Woditschka S, Haag JD, Sullivan R, Gould MN.

Cancer Prev Res (Phila). 2009 Feb;2(2):153-60. doi: 10.1158/1940-6207.CAPR-08-0114.


Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.

Lubet RA, Boring D, Steele VE, Ruppert JM, Juliana MM, Grubbs CJ.

Cancer Prev Res (Phila). 2009 Feb;2(2):161-7. doi: 10.1158/1940-6207.CAPR-08-0134.


Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.

Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN.

Cancer Res. 1992 Aug 1;52(15):4102-5.


Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.

Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N, Chatterton RT, Liu B, Wang Q, Kim A, Murthy S, Thor AD.

Cancer Res. 2003 May 15;63(10):2425-33.


Bexarotene induces cellular senescence in MMTV-Neu mouse model of mammary carcinogenesis.

Shilkaitis A, Bratescu L, Green A, Yamada T, Christov K.

Cancer Prev Res (Phila). 2013 Apr;6(4):299-308. doi: 10.1158/1940-6207.CAPR-12-0260. Epub 2013 Feb 19.


Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure.

Bischoff ED, Heyman RA, Lamph WW.

J Natl Cancer Inst. 1999 Dec 15;91(24):2118.


Androgen-dependent mammary carcinogenesis in rats transgenic for the Neu proto-oncogene.

Watson PA, Kim K, Chen KS, Gould MN.

Cancer Cell. 2002 Jul;2(1):67-79.


Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene.

Rao GN, Ney E, Herbert RA.

Breast Cancer Res Treat. 1999 Dec;58(3):241-54.


Diet-gene interactions in estrogen-induced mammary carcinogenesis in the ACI rat.

Harvell DM, Strecker TE, Xie B, Buckles LK, Tochacek M, McComb RD, Shull JD.

J Nutr. 2001 Nov;131(11 Suppl):3087S-91S.


Prevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1alpha-hydroxyvitamin D(5).

Mehta R, Hawthorne M, Uselding L, Albinescu D, Moriarty R, Christov K, Mehta R.

J Natl Cancer Inst. 2000 Nov 15;92(22):1836-40.


Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer prevention.

Rodríguez-Burford C, Lubet RA, Steele VE, Eto I, Bandy M, Juliana MM, Weiss HL, Grizzle WE, Kelloff GJ, Grubbs CJ.

Oncol Rep. 2001 Mar-Apr;8(2):373-9.


Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program.

Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, McCormick DL, Pereira MA, Crowell JA, Bagheri D, et al.

J Cell Biochem Suppl. 1994;20:32-54. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk